SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.19 CNY | +1.35% |
|
+3.02% | -7.35% |
| 04-24 | Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator | MT |
| 04-18 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 23.43 | 28.93 | 26.10 |
| Spread/Res. | -1.02% | -19.84% | -11.15% |
| Spread/Supp. | +3.76% | +9.44% | +7.81% |
| Support | 22.35 | 21.19 | 21.51 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 600196 Stock
- Charts Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
